Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Details

Connection

William Greenfield to Female

This is a "connection" page, showing publications William Greenfield has written about Female.

 
Connection Strength
  
 
 
0.120
  
  1. Nakagawa M, Spencer HJ, Coleman HN, Greenfield WW. Distribution of human papillomavirus (HPV) types and anti-HPV T-cell immune responses among different racial/ethnic groups in Central Arkansas. J Ark Med Soc. 2013 Jan; 109(8):160-3.
    View in: PubMed
    Score: 0.026
  2. Nakagawa M, Gupta SK, Coleman HN, Sellers MA, Banken JA, Greenfield WW. A favorable clinical trend is associated with CD8 T-cell immune responses to the human papillomavirus type 16 e6 antigens in women being studied for abnormal pap smear results. J Low Genit Tract Dis. 2010 Apr; 14(2):124-9.
    View in: PubMed
    Score: 0.021
  3. Callaghan-Koru JA, Newman Chargois P, Tiwari T, Brown CC, Greenfield W, Koru G. Public Maternal Health Dashboards in the United States: Descriptive Assessment. J Med Internet Res. 2024 Sep 17; 26:e56804.
    View in: PubMed
    Score: 0.014
  4. Shibata T, Nakagawa M, Coleman HN, Owens SM, Greenfield WW, Sasagawa T, Robeson MS. Evaluation of DNA extraction protocols from liquid-based cytology specimens for studying cervical microbiota. PLoS One. 2021; 16(8):e0237556.
    View in: PubMed
    Score: 0.012
  5. Ravilla R, Coleman HN, Chow CE, Chan L, Fuhrman BJ, Greenfield WW, Robeson MS, Iverson K, Spencer H, Nakagawa M. Cervical Microbiome and Response to a Human Papillomavirus Therapeutic Vaccine for Treating High-Grade Cervical Squamous Intraepithelial Lesion. Integr Cancer Ther. 2019 Jan-Dec; 18:1534735419893063.
    View in: PubMed
    Score: 0.010
  6. Coleman HN, Greenfield WW, Stratton SL, Vaughn R, Kieber A, Moerman-Herzog AM, Spencer HJ, Hitt WC, Quick CM, Hutchins LF, Mackintosh SG, Edmondson RD, Erickson SW, Nakagawa M. Human papillomavirus type 16 viral load is decreased following a therapeutic vaccination. Cancer Immunol Immunother. 2016 May; 65(5):563-73.
    View in: PubMed
    Score: 0.008
  7. Magann EF, Ounpraseuth ST, Miller CD, Novotny SA, Lee NM, Greenfield WW, Morrison JC. Maternal and perinatal outcomes of indicated inductions of labor. J Matern Fetal Neonatal Med. 2016; 29(14):2240-4.
    View in: PubMed
    Score: 0.008
  8. Stratton SL, Spencer HJ, Greenfield WW, Low G, Hitt WC, Quick CM, Jeffus SK, Blackmon V, Nakagawa M. A novel use of a statewide telecolposcopy network for recruitment of participants in a Phase I clinical trial of a human papillomavirus therapeutic vaccine. Clin Trials. 2015 Jun; 12(3):199-204.
    View in: PubMed
    Score: 0.007
  9. Kim KH, Greenfield WW, Cannon MJ, Coleman HN, Spencer HJ, Nakagawa M. CD4+ T-cell response against human papillomavirus type 16 E6 protein is associated with a favorable clinical trend. Cancer Immunol Immunother. 2012 Jan; 61(1):63-70.
    View in: PubMed
    Score: 0.006
  10. Winfield HL, De Las Casas LE, Greenfield WW, Santin AD, McKenney JK. Low-grade fibromyxoid sarcoma presenting clinically as a primary ovarian neoplasm: a case report. Int J Gynecol Pathol. 2007 Apr; 26(2):173-6.
    View in: PubMed
    Score: 0.004
  11. Kim KH, Greenfield W, Shotts E, Nakagawa M. Detection of human papillomavirus type 16-specific T lymphocytes by a recombinant vaccinia virus-based enzyme-linked immunospot assay. Clin Vaccine Immunol. 2007 Apr; 14(4):362-8.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.